Center for Innovation in Global Health Technologies, Biomedical Engineering, 2145 Sheridan Road E310, Northwestern University, Evanston, IL 60208-3107, USA.
Biosens Bioelectron. 2013 Apr 15;42:69-75. doi: 10.1016/j.bios.2012.10.024. Epub 2012 Oct 17.
A low-cost, fully integrated sample-to-answer, quantitative PCR (qPCR) system that can be used for detection of HIV-1 proviral DNA in infants at the point-of-care in resource-limited settings has been developed and tested. The system is based on a novel DNA extraction method, which uses a glass fiber membrane, a disposable assay card that includes on-board reagent storage, provisions for thermal cycling and fluorescence detection, and a battery-operated portable analyzer. The system is capable of automated PCR mix assembly using a novel reagent delivery system and performing qPCR. HIV-1 and internal control targets are detected using two spectrally separated fluorophores, FAM and Quasar 670. In this report, a proof-of-concept of the platform is demonstrated. Initial results with whole blood demonstrate that the test is capable of detecting HIV-1 in blood samples containing greater than 5000 copies of HIV-1. In resource-limited settings, a point-of-care HIV-1 qPCR test would greatly increase the number of test results that reach the infants caregivers, allowing them to pursue anti-retroviral therapy.
我们研发并测试了一种低成本、完全集成的、可现场使用的定量 PCR(qPCR)系统,该系统可用于在资源有限的环境中对婴儿进行 HIV-1 前病毒 DNA 的检测。该系统基于一种新颖的 DNA 提取方法,使用玻璃纤维膜、一次性检测卡,其中包括内置试剂储存、热循环和荧光检测设施,以及电池供电的便携式分析仪。该系统能够使用新型试剂输送系统自动进行 PCR 混合液装配,并执行 qPCR。使用两种光谱分离的荧光染料 FAM 和 Quasar 670 检测 HIV-1 和内参靶标。本报告证明了该平台的概念验证。全血的初步结果表明,该检测能够检测到血液样本中 HIV-1 拷贝数大于 5000 的 HIV-1。在资源有限的环境中,现场即时 HIV-1 qPCR 检测将大大增加到达婴儿照顾者的检测结果数量,使他们能够接受抗逆转录病毒治疗。